Mesoblast

$9.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.58 (-5.74%) Today
+$0.01 (+0.15%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Mesoblast and other stocks, options, and ETFs commission-free!

About MESO

Mesoblast Limited American Depositary Shares, also called Mesoblast, is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia. The listed name for MESO is Mesoblast Limited American Depositary Shares.

CEO
Silviu Itescu
Employees
102
Headquarters
Melbourne, Victoria (VIC)
Founded
2004
Market Cap
1.12B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
659.40K
High Today
$10.21
Low Today
$9.49
Open Price
$10.21
Volume
550.15K
52 Week High
$21.28
52 Week Low
$3.12

MESO Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Mar 9, After Hours

You May Also Like

LMB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure